We are live on
!
Find out more
MCP
Martin Capital Partners Portfolio holdings
AUM
$272M
1-Year Est. Return
19.09%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$96.3M
AUM Growth
–
Cap. Flow
+$93.6M
Cap. Flow
% of AUM
97.2%
Top 10 Holdings %
Top 10 Hldgs %
38.32%
Holding
44
New
44
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.52M |
| 2 |
Pfizer
PFE
|
+$4.19M |
| 3 |
Cisco
CSCO
|
+$3.95M |
| 4 |
Apple
AAPL
|
+$3.56M |
| 5 |
Boeing
BA
|
+$3.51M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.52% |
| 2 | Healthcare | 15.6% |
| 3 | Consumer Staples | 9.17% |
| 4 | Financials | 9.17% |
| 5 | Energy | 8.77% |
Similar funds
SC
SC
BLAM
TP
AGP
SFPG
S
SS
Martin Capital Partners's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Martin Capital Partners, which disclosed 44 positions worth $96.3M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Johnson & Johnson: 32,479 shares worth $4.54M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Healthcare and Consumer Staples.
- Martin Capital Partners's largest Q4 2017 buy was Johnson & Johnson: 32,479 shares worth $4.54M.
- Martin Capital Partners's ten largest holdings make up 38% of its $96.3M portfolio in Q4 2017.
- Martin Capital Partners disclosed 44 positions in Q4 2017, its first 13F filing on record.
Based on Martin Capital Partners's 13F filing for Q4 2017, filed 13 Feb 2018.